CHOSEN is a dermatologist-led skincare brand building topical products and nutraceuticals for melanin-rich Indian skin, and it has raised $5 million in a Series A round led by Fireside Ventures. The problem it’s chasing is simple but stubborn: a lot of Indian skincare buyers still end up with routines shaped by trend cycles or borrowed global formulas instead of products designed for local climate, pigmentation patterns, and skin-of-colour needs. Founded in 2020 by cosmetic dermatologist Dr Renita Rajan, CHOSEN will use the new capital for research and development, clinically validated product launches, its dermatologist-led Centre of Excellence, and hiring across teams.
What is CHOSEN skincare and how does it work?
CHOSEN skincare starts with guided discovery, not a giant catalog dump. A new customer can enter through a “Routine Builder” or a “Concern Analyser,” answer questions on skin, climate, and daily exposure, and get a suggested regimen in roughly 2 minutes. There’s also a product-and-concern matching flow for shoppers who already know what category they want.
That matters because CHOSEN isn’t selling one hero cream and hoping the branding does the rest. The brand organizes its range around 4 ageing and skin-health domains that are especially relevant for Indian skin: pigmentation, texture, contour, and hair ageing. Its portfolio spans both topicals and ingestibles. That’s unusual for a young premium skincare brand, but it fits Dr Rajan’s broader skin-health framing.
The product details are pretty specific. SAFESCREEN NEXGEN is positioned as an “exposome defence” sunscreen with SPF 80+ PA++++, using bemotrizinol, plant melanin, and ashwagandha. It’s marketed as protecting against UV, infrared, and blue light without a white cast. Sculpt Serum takes a different lane — CHOSEN calls it India’s first topical contouring serum with a published clinical study on submental fullness in Indian women. It’s built with DMAE, retinol, and OptiMSM for nightly use.
So the before-and-after customer experience is less about “buy 10 actives and experiment” and more about a short guided intake and a narrower routine. The products are framed around clinically defined use cases. That’s a smart way to sell premium skincare in India right now. Consumers are more ingredient-aware, but also more confused than they were 5 years ago.
Who founded CHOSEN skincare and why was it started?
A clinic-built origin story
CHOSEN was founded in 2020 by Dr Renita Rajan, and the company timeline ties the launch to a Chennai flagship plus the debut of its online store and 5 founding products. The brand didn’t begin as a generic D2C beauty play. In a 2026 profile, Rajan described building it after repeatedly seeing topical steroid damage, barrier dysfunction, and long-term pigmentation issues in practice — basically, too many patients arriving after using the wrong products for too long.
Why Dr Renita Rajan had founder-market fit
Rajan’s credibility here is real. She holds an MBBS, an MD in Dermatology, Venereology and Leprosy, and a DNB in Dermatology and Venereology. She trained at Christian Medical College, Vellore, worked as a postgraduate registrar and research associate there, and later served as an assistant professor at Sri Ramachandra University. Rajan also runs Render Skin & Hair in Chennai. She has published research, contributed to textbooks, and worked deeply in cosmetic dermatology and dermatosurgery.
That background changes how you read CHOSEN. This isn’t a marketer reverse-engineering a category from Instagram demand. It’s a specialist trying to commercialize what she has seen in clinic for more than 20 years. That usually produces better product judgment. It doesn’t automatically guarantee mass-brand scale.
Traction, early signals, and the new round
CHOSEN has disclosed some useful operating signals. Its brand page lists 70K+ users, 50+ products, and 2,000+ doctors prescribing the range. The same timeline shows a community crossing 30K in 2021 and the SAFESCREEN launch in 2022. It also shows an expansion into dermatologist-focused IZONIS products in 2024 and the 2026 release of Sculpt Serum with a published 12-week study in Indian women.
The fresh round is a $5 million Series A led by Fireside Ventures, with participation from BOLD — L’Oréal’s venture arm — and Alkemi Growth Capital. Angel investor Avnish Anand joined, along with practicing dermatologists including Chandan Asokan, KC Nischal, Punit Saraogi, Nishita Ranka, and Mikki Singh. Rajan called the round a validation of CHOSEN’s science-led, dermatologist-developed model and said it gives the company room to deepen R&D and bring more dermatologists into product development. It will also expand the evidence base around anti-ageing for Indian skin.
Where CHOSEN sits against competitors
The obvious competitive pressure comes from India’s newer science-backed skincare brands. The Derma Co, founded in 2020 under Honasa Consumer, is a much larger active-ingredient player with dermatologist-recommended positioning and broad category coverage. Fixderma comes from a more traditional dermaceutical lineage and emphasizes clinically proven improvement plus its own GMP-certified manufacturing base.
CHOSEN is taking a tighter lane than either of those. Its differentiation is built around premium dermatologist leadership and products designed specifically for melanin-rich Indian skin. It also leans on exposome-based formulation thinking and clinical validation as a brand asset rather than a side note. The older alternative, frankly, is still a messy mix of imported formulas, over-the-counter problem solvers, and social-media-led routines that weren’t built for Indian conditions in the first place.
Why are investors backing CHOSEN skincare now?
This round isn’t just about adding more SKUs. It’s about funding a harder kind of consumer brand — one that spends on research, published evidence, dermatologist relationships, and specialist hiring instead of leaning only on influencer velocity. CHOSEN will use the money to strengthen R&D and expand its clinically validated pipeline. It will also scale its Centre of Excellence and add talent across functions. That’s expensive work. It also takes time.
Fireside’s logic looks pretty clear. Varun Varma said the firm was drawn to CHOSEN’s mix of deep clinical rigor and a trust-led go-to-market. BOLD’s Samantha Etienne described the company as a science-led model anchored in a dermatologist network. Alkemi’s Alka Goel pointed to the doctor-led distribution flywheel and the unmet needs of skin of colour. Read together, it sounds like a bet that trust can become the moat — not just branding and not just formulation. Both have to work together.
How big is India’s dermocosmetics market?
The backdrop is large enough to matter. KPMG pegs India’s dermatology market at more than ₹16,000 crore in 2025, up from around ₹12,000 crore in 2021, with preventive skincare expected to be a major next leg of growth. A separate India skincare dermocosmetics forecast sees the market growing from $188.2 million in 2021 to $449.6 million by 2030. That implies a 10.2% CAGR.
The demand mix is also shifting in CHOSEN’s favor. IMARC says facial care held a 42.5% revenue share in India’s skincare market in 2025, helped by stronger demand for targeted serums and sunscreens. Treatment products are part of that shift too. Put that next to rising consumer interest in preventive skincare and you get the basic answer to “why now?” People aren’t buying skincare only for cosmetics anymore. A lot more of them are buying it like a health category.
What should you watch next for CHOSEN skincare?
CHOSEN skincare now has enough capital to prove whether clinic credibility can scale into a durable premium consumer brand. The next thing to watch isn’t just product count. It’s whether the company can turn R&D and dermatologist prescribing into repeat purchase. Long-term brand trust is the other test, especially if it wants to avoid slipping into generic beauty marketing.
Read how HealthFab raised ₹20 Cr in a Series A led by Atomic Capital to scale its reusable period underwear and expand into a broader menstrual wellness portfolio, aiming to move beyond disposable pads with sustainable, high-absorbency products like GoPadFree designed for comfort, reusability, and everyday convenience.
FAQ
– What funding did CHOSEN raise?
CHOSEN raised $5 million in a Series A round announced on May 4, 2026. Fireside Ventures led the round, with participation from BOLD, Alkemi Growth Capital, angel investor Avnish Anand, and a group of practicing dermatologists.
– How does CHOSEN skincare work for customers?
CHOSEN uses a guided shopping flow that starts with a Routine Builder or a Concern Analyser, both designed to take under 2 minutes. Customers answer questions about skin, climate, and exposure, then get product suggestions tied to concerns like pigmentation, texture, contour, and hair ageing.
– Who is Dr Renita Rajan?
Dr Renita Rajan is a cosmetic dermatologist and the founder of CHOSEN, which she launched in 2020. She trained at Christian Medical College, Vellore, holds MD and DNB dermatology qualifications, taught at Sri Ramachandra University, and built her practice at Render Skin & Hair in Chennai before turning clinical insight into a consumer brand.
– Is CHOSEN a dermocosmetics brand or a regular beauty brand?
It sits much closer to dermocosmetics than to a standard beauty label. CHOSEN combines dermatologist-led product development and evidence-backed positioning. It also focuses on treatment-oriented categories, which places it alongside science-based Indian players such as The Derma Co and Fixderma in a market projected to reach $449.6 million in India by 2030.
